+612 9045 4394
 
CHECKOUT
Current Trends in Monoclonal Antibody Development and Manufacturing : Biotechnology: Pharmaceutical Aspects - Steve Shire

Current Trends in Monoclonal Antibody Development and Manufacturing

Biotechnology: Pharmaceutical Aspects

By: Steve Shire (Editor), Wayne Gombotz (Editor), Karoline Bechtold-Peters (Editor), James Andva (Editor)

Hardcover

Published: 1st November 2009
Ships: 7 to 10 business days
7 to 10 business days
RRP $775.99
$537.50
31%
OFF
or 4 easy payments of $134.38 with Learn more

Monoclonal antibodies represent one of the fastest growing areas of new drug development within the pharmaceutical industry. Several blockbuster products have been approved over the past several years including Rituxan, Remicade, Avastin, Humira, and Herceptin. In addition, over 300 new drugs are currently in clinical trials. With both large, established biotechnology companies and small start-ups involved in the development of this important class of molecules, monoclonal antibodies products will become increasingly prevalent over the next decade.

Recently the regulatory review of monoclonal antibodies has been moved from Center for Biologics and Research to the Center for Drug Evaluation and Research (CDER) division of the US Food and Drug Administration. It is anticipated that CDER will expect a certain minimal amount of data to be provided as more of these products move through the regulatory pipeline. Current Trends in Monoclonal Antibody Development and Manufacturing will provide readers with an understanding of what is currently being done in the industry to develop, manufacture, and release monoclonal antibody products and what will be required for a successful regulatory submission.

Introduction.- Design of Therapeutic Monoclonal Antibodies.- Manufacturing of Monoclonal Antibodies/Expression and Production of Monoclonal Antibodies.- Manufacturing of Monoclonal Antibodies/ Recovery and Purification of Bulk Drug Substance.- Formulation and Delivery Challenges.- Analytics and Specification Setting of MAbs.- Pharmacokinetics of Mabs.- Clinics and Toxicology.- Future Trends.

ISBN: 9780387766423
ISBN-10: 0387766421
Series: Biotechnology: Pharmaceutical Aspects : Book 11
Audience: Professional
Format: Hardcover
Language: English
Number Of Pages: 354
Published: 1st November 2009
Publisher: Springer-Verlag New York Inc.
Country of Publication: US
Dimensions (cm): 25.4 x 18.42  x 2.54
Weight (kg): 0.97